Molecular Drivers of Potential Immunotherapy Failure in Adrenocortical Carcinoma

Adrenocortical carcinoma (ACC) is a rare, highly aggressive cancer, often insensitive to conventional chemotherapeutics agents. Early diagnosis, followed by radical surgical resection plus/minus adjuvant mitotane therapy, is nowadays the only valuable option. Unfortunately, one out of four patients...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Oncol
Autors principals: Fiorentini, Chiara, Grisanti, Salvatore, Cosentini, Deborah, Abate, Andrea, Rossini, Elisa, Berruti, Alfredo, Sigala, Sandra
Format: Artigo
Idioma:Inglês
Publicat: Hindawi 2019
Matèries:
Review Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6463568/
https://ncbi.nlm.nih.gov/pubmed/31057613
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2019/6072863
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars